mRNA-1273.214 stimulated almost twice the neutralising antibody levels against the Omicron strain than Spikevax, with a significantly higher response also seen against other variants of concern ...
giving a green light to Moderna's mRNA-1273.214 shot. The new vaccine is an updated version of Moderna's widely-use Spikevax vaccine, which includes sequences from the original Wuhan strain of ...
Moderna's Spikevax KP.2 targets the KP.2 variant of the virus. The U.S. Food and Drug Administration has also approved the shot, as well as updated vaccines from Pfizer and BioNTech. Moderna (MRNA ...
Moderna said the Spikevax 2024-2025 formula is expected to be available across the U.S. in the days immediately following approval. Pfizer also said shipping will begin immediately. Thursday ...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
Spikevax 2024-2025 formula expected to be available in pharmacies and care settings across the U.S. in the days immediately following approval CAMBRIDGE, MA / ACCESSWIRE / August 22, 2024 ...
SPIKEVAX ® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians this fall and winter season. Moderna will promptly ...
Image Source: Zacks Investment Research Spikevax, targeting the variant JN.1., is currently approved in the United States, the United Kingdom, Japan and Taiwan. Last month, the FDA approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback